Skip to main content

Table 3 Univariate and multiple logistic regression analysis of demographic and clinical factors associated with all-cause mortality among pneumococcal disease patients

From: Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study

Characteristics

Died (N = 70), N(%)

Survived (N = 426), N(%)

OR (95%CI)

p value

AOR (95% CI)

p value

Age, mean (years) ± SD

74.4 ± 14.3

68.2 ± 15.4

 

< 0.001

  

Age group

  < 65 years

16 (22.9)

154 (36.2)

Ref

Ref

Ref

Ref

 65-74 years

18 (25.7)

107 (25.1)

1.62 (0.79–3.32)

0.188

1.70 (0.69–4.15)

0.246

 75-84 years

16 (22.9)

115 (27.0)

1.34 (0.64–2.79)

0.435

1.99 (0.80–4.94)

0.138

  ≥ 85 years

20 (28.6)

50 (11.7)

3.85 (1.85–8.00)

< 0.001

10.78 (4.10–28.37)

< 0.001

Gender = male

45 (64.3)

280 (65.7)

0.94 (0.55–1.59)

0.814

1.05 (0.55–1.98)

0.892

Ethnicity

 Chinese

51 (72.9)

308 (72.3)

Ref

Ref

  

 Malay

9 (12.9)

52 (12.2)

1.05 (0.49–2.25)

0.910

  

 Indian

7 (10.0)

32 (7.5)

1.32 (0.55–3.15)

0.530

  

 Others

3 (4.3)

34 (8.0)

0.53 (0.16–1.80)

0.311

  

Vaccination status (received ≥ 14 days prior to admission)

 Any pneumococcal vaccination

7 (10.0)

73 (17.1)

0.54 (0.24–1.22)

0.138

  

 Influenza vaccination in past 1 yr

8 (11.4)

67 (15.7)

0.69 (0.32–1.51)

0.354

  

Co-morbidities

 Charlson’s score, median (IQR)

1 (0–4)

2 (1–4)

 

< 0.001

  

 Charlson’s score > 3

30 (42.7)

107 (25.1)

2.24 (1.33–3.77)

0.002

1.93 (1.02–3.64)

0.042

 Myocardial infarction / Congestive heart failure

30 (42.9)

113 (26.5)

2.08 (1.24–3.49)

0.006

  

 Cerebrovascular disease

17 (24.3)

49 (11.5)

2.47 (1.33–4.60)

0.004

  

 Dementia

16 (22.9)

38 (8.9)

3.03 (1.58–5.79)

0.001

  

 Chronic pulmonary disease

16 (22.9)

133 (31.2)

0.65 (0.36–1.18)

0.160

  

 Liver disease

3 (4.3)

24 (5.6)

0.75 (0.22–2.56)

0.997

  

 Diabetes mellitus

24 (34.3)

123 (28.9)

1.29 (0.75–2.20)

0.409

  

 Renal disease

16 (22.9)

77 (18.1)

1.34 (0.73–2.47)

0.343

  

 Any malignancy

12 (17.1)

41 (9.6)

1.94 (0.97–3.91)

0.063

  

Invasive pneumococcal disease

24 (34.3)

68 (16.0)

2.75 (1.57–4.80)

< 0.001

3.19 (1.55–6.59)

0.002

Outcomes

 ICU admission

31 (44.3)

23 (5.4)

13.93 (7.40–26.19)

< 0.001

23.22 (11.07–48.70)

< 0.001

 Length of stay (days), median (IQR)

7 (4–21)

8 (6–15)

 

0.081

  

 Length of stay > 7 days

33 (47.1)

242 (56.8)

1.08 (0.90–1.29)

0.414

  
  1. Variables included in the final multivariable analysis were age group, gender, Charlson’s score > 3, diagnosis of invasive pneumococcal disease, and intensive care unit admission. OR odds ratio, CI confidence interval, AOR adjusted OR, SD standard deviation, IQR inter-quartile range, ICU intensive care unit